Comparison of Serum Level of Magnesium in Patients Received Pantoprazole or Ranitidine in Intensive Care Unit

Document Type : Original Article (s)

Authors

1 Assistant Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Some of studies showed that using proton-pump inhibitors (PPIs) in hospitalized patients is one of the causes of decreased serum magnesium level that leads to electrolytic imbalance. This study aimed to compare serum level of magnesium in patients who received pantoprazole or ranitidine in intensive care unit.Methods: In a clinical trial study, 50 patients hospitalized in intensive care units of Alzahra hospital, Isfahan, Iran, were randomly divided in to two groups of 25. Patients were treated with pantoprazole and ranitidine in first and second groups, respectively. Serum level of magnesium was measured during two weeks after entrance to intensive care units and compared between the groups.Findings: Mean serum level of magnesium in the two groups of pantoprazole and ranitidine in second day of hospitalization was 1.90 ± 0.11 and 1.98 ± 0.13 mg/dl, respectively and there was statistically difference between the two groups (P = 0.017). Serum level of magnesium until the 10th day of hospitalization was significantly different between the two groups. In addition, the trend of serum level of magnesium was different between the two groups (P < 0.001).Conclusion: Our study showed that consumption of ranitidine led to less decrease of serum level of magnesium among patients hospitalized in internal care units. But, considering our limitations as the amount of cases, more studies on using ranitidine are recommended.

Keywords

References

  1. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm 2005; 62(16): 1663-82.
  2. Satish R, Gokulnath G. Serum magnesium in recovering acute renal failure. Indian J Nephrol 2008; 18(3): 101-4.
  3. Deheinzelin D, Negri EM, Tucci MR, Salem MZ, da Cruz VM, Oliveira RM, et al. Hypomagnesemia in critically ill cancer patients: a prospective study of predictive factors. Braz J Med Biol Res 2000; 33(12): 1443-8.
  4. Novello NP, Blumstein HA. Hypomagnesemia [Online]. [cited 2007]; Available from: URL: http://misc.medscape.com/pi/iphone/medscapeapp/html/A767546-business.html
  5. Rahimi M, Montazeri K, Kamali L, Moradi M, Naghibi Kh. Comparing the effects of magnesium sulfate and nitroglycerin on the control of hypertension during and after cataract surgery under local anesthesia and intravenous sedation. J Isfahan Med Sch 2016; 33(361): 2076-83. [In Persian].
  6. Liu D, Steele D. Fluid, electrolytes, acid base. In: Bigatello L, Allain RM, Haspel KL, Hellman J, Hess DR, editors. Critical care handbook of the massachusetts general hospital. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005. p. 126-54.
  7. Andreoli TE, Carpenter CJ, Griggs RC. Cecil essentials of medicine. 7th ed. Philadelphia, PA: WB Saunders; 2007. p. 417-8.
  8. Katzung BG, Trevor AJ, Kruidering-Hall M. Katzung and Trevor's pharmacology: examination and board review. 11th ed. New York, NY: McGraw-Hill; 2008. p. 1067-75.
  9. Taylor PC, Loop FD, Hermann RE. Management of acute stress ulcer after cardiac surgery. Ann Surg 1973; 178(1): 1-5.
  10. Fujita K, Hata M, Sezai A, Sekino H, Minami K. Is prophylactic intravenous administration of a proton pump inhibitor necessary for perioperative management of cardiac surgery? Heart Surg Forum 2012; 15(5): E277-E279.
  11. Vincent JL, Patrick EA, Frederick K, Fink MM. Textbook of critical care. 6th ed. Philadelphia, PA: Saunders; 2011. p. 86-91.
  12. Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Miller's anesthesia. 7th ed. London, UK: Churchill Livingstone; 2011. p. 218.
  13. Brunicardi F, Andersen D, Billiar T, Dunn D, Hunter J, Matthews J, et al. Schwartz's principles of surgery. 9th ed. New York, NY: McGraw-Hill; 2009. p. 333.
  14. Shin JS, Abah U. Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 2012; 14(5): 622-8.
  15. Toh JW, Ong E, Wilson R. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterol Rep (Oxf) 2015; 3(3): 243-53.
  16. El-Charabaty E, Saifan C, Abdallah M, Naboush A, Glass D, Azzi G, et al. Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias. Int J Gen Med 2013; 6: 515-8.
  17. Zafar MS, Wani JI, Karim R, Mir MM, Koul PA. Significance of serum magnesium levels in critically ill-patients. Int J Appl Basic Med Res 2014; 4(1): 34-7.
  18. Valizadeh Hassanlouei MA, Hassani E, Rahimi Rad MH, Adeli SH, Karimi Sakhvidi N, Boudag H. Evaluation of serum magnesium and the effect on prognosis in patients admitted to intensive care unit. J Urmia Univ Med Sci 2013; 24(1): 30-7. [In Persian].
Journal of Isfahan Medical School
Volume 35, Issue 432 - Serial Number 432
March and April 2017
Pages 615-621

Files

History

  • Receive Date: 29 January 2017
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics